Contrast Injector Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Injector Systems, Consumables), By Application (Radiology, Intervention Radiology, Intervention Cardiology), By End Users (Hospitals And Clinics, Diagnostic Centers) And Geography - Forecasts From 2019 To 2024

The contrast injector market is projected to expand at a CAGR of 7.01% to reach US$748.350 million in 2024 from US$498.483 million in 2018.

Medical devices employed for injecting radio-opaque contrast media into the body to enhance the visibility of tissues for a medical imaging procedure are known as contrast injectors. Over the years, with technological advancement, these contrast injectors have evolved from manual injectors having manifolds with stop-cocks to automated versions, providing added accuracy and advantages.

The rapidly growing geriatric population along with the increasing number of chronic diseases is the key factor that drives the growth of the market. Increasing adoption of minimally invasive techniques along with the increase in investment in the healthcare sector in developing economies is also considered the key driver for the growth of the market. Technological advancement in contrast media injectors also fuels the growth of the market. However high cost associated with contrast media injectors is considered the restraining factor for the growth of the market.

By product, consumables are projected to account for a significant market share due to their use in diagnostic procedures to maintain hygiene. By geography, the Asia Pacific region is expected to have a significant growth rate during the forecast period owing to rising healthcare expenditure in the region and the growing presence of international players.

DRIVERS
• The growing geriatric population along with an increase in chronic diseases
• Technological advancement in contrast to media injectors
• Increasing investments in healthcare in developing nations

RESTRAINTS
• Health concerns regarding side effects and allergies due to contrast agents

INDUSTRY UPDATE

• In November 2018, Guerbet, a global specialist in contrast agents and solutions for medical imaging, announced that the OptiVantage®multi-use injector is now CE-marked. This injector is designed for injecting contrast agents used in X-ray (CT scan) medical examinations with no compromise in efficiency and patient safety.

• As per the 2016 report, Syringeless injectors, new systems for CT and MR contrast, and integration with EMR/PACS for dose analytics are among the major driving forces in contrast media injector technology.

Contrast Injector Market Scope:

SEGMENTATION

The contrast injector market has been analyzed through the following segments:

• By product
o Injector Systems
o Consumables

• By application
o Radiology
o Intervention radiology
o Intervention cardiology

• By End Users
o Hospitals and Clinics
o Diagnostic Centers

• By Geography
• North America
o USA
o Canada
o Mexico

• South America
o Brazil
o Argentina
o Others

• Europe
o Germany
o France
o United Kingdom
o Spain
o Others

• Middle East and Africa
o Saudi Arabia
o Israel
o Others

• Asia Pacific
o China
o Japan
o South Korea
o India
o Others